Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Net Sales
1,870.25
1,686.67
2,014.69
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,870.25
1,686.67
2,014.69
Raw Material Cost
1,242.75
1,533.15
1,312.96
Purchase of Finished goods
17.80
12.32
10.75
(Increase) / Decrease In Stocks
124.61
-368.43
60.31
Employee Cost
125.35
118.18
116.55
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
256.09
257.92
367.89
Total Expenditure (Excl Depreciation)
1,766.60
1,553.13
1,868.46
Operating Profit (PBDIT) excl Other Income
103.65
133.54
146.23
Other Income
16.66
14.40
8.39
Operating Profit (PBDIT)
120.31
147.94
154.62
Interest
71.79
75.56
72.79
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
48.52
72.38
81.83
Depreciation
50.06
59.93
50.08
Profit Before Tax
-1.54
12.45
31.75
Tax
21.88
0.15
12.11
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-23.41
12.30
19.64
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-23.41
12.30
19.64
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-23.41
12.30
19.64
Equity Capital
51.18
41.94
41.94
Face Value
10.0
10.0
10.0
Reserves
730.79
458.74
447.51
Earnings per share (EPS)
-4.57
2.93
4.68
Diluted Earnings per share
-5.11
2.93
4.68
Operating Profit Margin (Excl OI)
5.54%
7.92%
7.26%
Gross Profit Margin
2.59%
4.29%
4.06%
PAT Margin
-1.25%
0.73%
0.97%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 10.88% vs -16.28% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is -290.33% vs -37.37% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -22.38% vs -8.68% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -4.99% vs 3.81% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Godavari Bioref. With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
1,870.25
76.99
1,793.26
2,329.21%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,870.25
76.99
1,793.26
2,329.21%
Raw Material Cost
1,242.75
33.77
1,208.98
3,580.04%
Purchase of Finished goods
17.80
7.45
10.35
138.93%
(Increase) / Decrease In Stocks
124.61
-2.93
127.54
4,352.90%
Employee Cost
125.35
6.87
118.48
1,724.60%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
256.09
6.19
249.90
4,037.16%
Total Expenditure (Excl Depreciation)
1,766.60
51.34
1,715.26
3,340.98%
Operating Profit (PBDIT) excl Other Income
103.65
25.65
78.00
304.09%
Other Income
16.66
0.14
16.52
11,800.00%
Operating Profit (PBDIT)
120.31
25.79
94.52
366.50%
Interest
71.79
2.91
68.88
2,367.01%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
48.52
22.88
25.64
112.06%
Depreciation
50.06
0.76
49.30
6,486.84%
Profit Before Tax
-1.54
22.12
-23.66
-106.96%
Tax
21.88
5.62
16.26
289.32%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-23.41
16.50
-39.91
-241.88%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-23.41
16.50
-39.91
-241.88%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
-0.62
0.62
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-23.41
15.88
-39.29
-247.42%
Equity Capital
51.18
13.29
37.89
285.10%
Face Value
10.00
10.00
0.00
Reserves
730.79
23.80
706.99
2,970.55%
Earnings per share (EPS)
-4.57
11.95
-16.52
-138.24%
Diluted Earnings per share
-5.11
14.11
-19.22
-136.22%
Operating Profit Margin (Excl OI)
5.54%
33.32%
0.00
-27.78%
Gross Profit Margin
2.59%
29.72%
0.00
-27.13%
PAT Margin
-1.25%
21.43%
0.00
-22.68%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,870.25 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 10.88% vs -16.28% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -23.41 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -290.33% vs -37.37% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 103.65 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -22.38% vs -8.68% in Mar 2024
Annual - Interest
Interest 71.79 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -4.99% vs 3.81% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.54%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024






